# Liposomal Cancer Drug Database (LCDD): a comprehensive resource for liposome research in cancer therapy and diagnosis

## TL;DR

The LCDD is a free database compiling data on liposome-based cancer treatments and diagnostics from thousands of research articles.

## Contribution

The novelty lies in compiling and categorizing liposome-based cancer research data into a freely accessible database for noncommercial use.

## Key findings

- LCDD includes data from about 4500 research articles with 14 key attributes per entry.
- The database supports cancer therapy, diagnostics, and theragnostic research.
- LCDD is available for noncommercial use at a specified URL.

## Abstract

The Liposomal Cancer Drug Database (LCDD) is a comprehensive web-based resource that provides an extensive overview of liposome-based formulations used in cancer therapy and diagnostics. LCDD compiles data from about 4500 research articles, categorizing information into 14 key attributes for each research article such as type of cancer, liposome size, type of experiments, cell line type, in vivo animals, liposome function, and type of cargo. The database is built on direct literature investigations and serves as a critical tool for researchers developing liposome-based cancer therapeutic drugs, diagnostic platforms, or theragnostic solutions. LCDD is available for noncommercial purposes as a free database at https://bioinformaticscollege.ir/lcdd/.